Healthcare and Life Sciences CFO Insights
CFO Insights
CFOs are leading the path for transformation.
CFOs are leading the path for transformation
-
Opportunities in an evolving market
Opportunities in an evolving market
2019 Health Care & Life Sciences Investment Outlook
2019 Health Care & Life Sciences Investment Outlook
-
On the 2019 healthcare board agenda
On the 2019 healthcare board agenda
Board and audit committee agendas should continue to evolve in 2019 amid the game-changing implications of technology, consolidation, and new entrants.
Board and audit committee agendas should continue to evolve in 2019 amid the game-changing implications of technology, consolidation, and new entrants.
-
Revenue for the life sciences industry:
Revenue for the life sciences industry:
New standard. New challenges.
New standard. New challenges.
THE CFO AGENDA
With a shift from volume to value, decreased margins, and portfolio rationalization, healthcare and life sciences CFOs must navigate a sea of change. Learn how KPMG can assist CFOs improve operational effectiveness, implement strategic plans, drive profitable growth, and instate a governance model.
Connect with us
- Find office locations kpmg.findOfficeLocations
- Email us kpmg.emailUs
- Social media @ KPMG kpmg.socialMedia
Want to do business with KPMG?
